Estradiol vaginal inserts (4 µg and 10 µg) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic data.

Document Type

Journal Article

Publication Date

12-1-2018

Journal

Current medical research and opinion

Volume

34

Issue

12

Inclusive Pages

2131-2136

DOI

10.1080/03007995.2018.1527578

Peer Reviewed

1

Find in your library

Share

COinS